Arcuate Nucleus NPY/AgRP Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Arcuate Nucleus NPY/AgRP Neurons</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4072017](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4072017](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Paraventricular Nucleus (PVH)</td>
<td>NPY, AgRP, GABA</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamic Area (LHA)</td>
<td>NPY, GABA</td>
</tr>
<tr>
<td class="label">Parabrachial Nucleus</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Bed Nucleus of Stria Terminalis (BNST)</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Preoptic Area</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Dorsal Raphe Nucleus</td>
<td>NPY</td>
</tr>
<tr>
<td class="label">Ventral Tegmental Area</td>
<td>NPY</td>
</tr>
</table>
Arcuate Nucleus Npy Agrp Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neuropeptide Y (NPY) and agouti-related peptide (AgRP) co-expressing neurons in the arcuate nucleus are the primary orexigenic (appetite-stimulating) neurons in the hypothalamus. They drive feeding behavior, regulate energy storage, and modulate stress responses. These neurons are central to energy homeostasis and have been increasingly recognized for their roles in neurodegenerative diseases[@luquet2005]. [@rodriguez2010]
Overview
[@ollmann1997]
<!-- multi-taxonomy-enrichment --> [@tong2008]
<!-- taxonomy-enrichment --> [@de2012]
Taxonomy & Classification
External Database Links
- [Cell Ontology (CL:4072017)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)
- [OBO Foundry (CL:4072017)](http://purl.obolibrary.org/obo/CL_4072017)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: agouti-related protein expressing neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
- [Cell Ontology (CL:4072017)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)
- [OBO Foundry (CL:4072017)](http://purl.obolibrary.org/obo/CL_4072017)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Neuroanatomy and Location
The arcuate nucleus (ARC) is located at the base of the hypothalamus, adjacent to the median eminence—a circumventricular organ with incomplete blood-brain barrier that allows peripheral metabolic signals to access ARC neurons[@rodriguez2010]. NPY/AgRP neurons constitute approximately 30-40% of neurons in the medial ARC and are strategically positioned to integrate hormonal and nutritional signals[@cowley1999].
Electrophysiological Properties
NPY/AgRP neurons exhibit unique electrophysiological characteristics:
- Tonic activity: These neurons show persistent firing even in the absence of synaptic input, maintaining a depolarized resting membrane potential[@sternson2005]
- Glucose sensitivity: Activated by low glucose levels through AMPK activation, and inhibited by high glucose[@fioramonti2007]
- Ghrelin response: The hunger hormone ghrelin directly activates NPY/AgRP neurons via the growth hormone secretagogue receptor (GHSR)[@cowley2001]
- Leptin inhibition: Leptin directly inhibits NPY/AgRP neurons through JAK-STAT signaling[@elias1999]
- Population synchronization: NPY/AgRP neurons exhibit coordinated activity patterns that amplify feeding signals[@mandelblatcerf2017]
Projection Patterns
NPY/AgRP neurons project to multiple brain regions, forming a distributed network:
Molecular Signaling
Neuropeptide Y (NPY)
NPY is a 36-amino acid peptide belonging to the pancreatic polypeptide family. It acts through five G-protein-coupled receptors (Y1-Y5), with Y1 and Y5 mediating orexigenic effects[@pedrazzini2003]:
- Y1 receptor: Primary mediator of NPY-induced feeding, expressed in PVH and LHA
- Y5 receptor: Involved in feeding motivation and energy homeostasis
- Y2 receptor: Autoreceptor on NPY terminals, modulates NPY release
AgRP is a 132-amino acid melanocortin antagonist that acts on melanocortin-3 and melanocortin-4 receptors (MC3R/MC4R) in the PVH, blocking α-MSH signaling and promoting feeding[@ollmann1997]. AgRP neurons co-release GABA, providing rapid synaptic inhibition of downstream targets[@tong2008].
NPY/AgRP in Neurodegeneration
Alzheimer's Disease
The metabolic dysfunction observed in Alzheimer's disease involves significant alterations in the NPY/AgRP system:
- Type 3 Diabetes Hypothesis: Brain insulin resistance in the ARC contributes to AD pathogenesis, with NPY/AgRP neurons showing impaired insulin and IGF-1 signaling[@de2012]
- Metabolic syndrome risk: Obesity and metabolic syndrome increase AD risk, partly through NPY system dysregulation
- Amyloid interaction: NPY has been shown to affect amyloid precursor protein (APP) processing and Aβ toxicity in cellular models[@rose2011]
- Neuroinflammation: AgRP may modulate microglial activation and neuroinflammatory responses
- Appetite disturbances: Early dysregulated appetite and weight changes in AD correlate with ARC dysfunction
- Leptin resistance: Common in both obesity and AD, linked to disease progression
Parkinson's Disease
- Weight loss: Progressive weight loss in PD patients is associated with NPY system dysfunction[@bachmann2013]
- Non-motor symptoms: Autonomic dysfunction in PD involves hypothalamic control systems including the ARC
- Alpha-synuclein pathology: Evidence of α-synuclein accumulation in hypothalamic nuclei including the ARC[@rietdijk2017]
- Melanocortin system: Dysregulation of melanocortin signaling contributes to metabolic symptoms in PD
Huntington's Disease
- Early hyperphagia: Increased appetite and weight gain are early features of HD, linked to NPY/AgRP hyperactivity[@van2011]
- Hypothalamic pathology: Post-mortem studies show NPY neuron loss in HD brains
- Metabolic alterations: NPY system changes contribute to the characteristic metabolic phenotype of HD
- Circadian disruption: NPY/AgRP rhythm alterations contribute to sleep and feeding disturbances
Amyotrophic Lateral Sclerosis (ALS)
- Metabolic dysfunction: ALS patients often show hypermetabolism, linked to NPY system changes
- Autonomic involvement: NPY/AgRP dysfunction may contribute to autonomic symptoms in ALS
- Neuroprotection: NPY has demonstrated neuroprotective properties in some ALS models
Therapeutic Targets
NPY Receptor Antagonists
- Y1 antagonists: BIBO3304 and Y1-selective compounds reduce food intake and may improve metabolic function[@turnbill2002]
- Y5 antagonists: CGP-71683 and selective Y5 antagonists reduce feeding motivation
Ghrelin System Modulation
- GHSR antagonists: Block ghrelin activation of NPY/AgRP neurons
- GHSR inverse agonists: Reduce constitutive activity of ghrelin receptors
- Leptin therapy: Being explored for hypothalamic dysfunction in neurodegeneration
- AMPK modulators: Target metabolic sensing in NPY/AgRP neurons
- GLP-1 agonists: Show promise for metabolic and neuroprotective effects
Melanocortin System
- MC4R agonists: Melanotan II reduces food intake but has side effects
- AgRP vaccination: Experimental approaches to neutralize AgRP
Cross-Links
- [Cell Types/Arcuate Nucleus POMC Neurons](/cell-types)
- [Cell Types/Paraventricular Nucleus](/cell-types)
- [Cell Types/Lateral Hypothalamic Area](/cell-types)
- [Mechanisms/Hypothalamic](/mechanisms)
- [Mechanisms/Brain Insulin Signaling](/mechanisms)
- [Diseases/Alzheimer's Disease](/diseases)
- [Diseases/Parkinson's Disease](/diseases)
- [Diseases/Huntington's Disease](/diseases)
- [Genes/NPY](/genes)
- [Genes/AGRP](/genes)
- [Proteins/Leptin](/proteins)
- [Proteins/Ghrelin](/proteins)
- [Cell](/mechanisms/dopaminergic-neuron-vulnerability)
Background
The study of Arcuate Nucleus Npy Agrp Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data